Studies of the longer-term effects of AMPK activation or inactivation in the beta cell have also given conflicting results, with impaired insulin secretion and glucose tolerance observed after the inactivation of both catalytic subunits [21, 22] despite improved glucose-stimulated insulin secretion (GSIS) in vitro [23]. Here, INS is linked to glucose measurement.